Electra Therapeutics targets up to $977.6 million valuation
Electra Therapeutics said in a Monday filing that it is targeting a valuation of up to $977.6 million for its U.S. initial public offering.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.